Annual CFI
-$5.00 M
-$5.00 M-100.00%
30 April 2024
Summary:
PharmaCyte Biotech annual cash flow from investing activities is currently -$5.00 million, with the most recent change of -$5.00 million (-100.00%) on 30 April 2024. During the last 3 years, it has fallen by -$5.00 million (-100.00%). PMCB annual CFI is now -3268.57% below its all-time high of $157.80 thousand, reached on 30 April 2006.PMCB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$7.00 M
-$7.00 M-100.00%
31 July 2024
Summary:
PharmaCyte Biotech quarterly cash flow from investing activities is currently -$7.00 million, with the most recent change of -$7.00 million (-100.00%) on 31 July 2024. Over the past year, it has dropped by -$7.00 million (-100.00%). PMCB quarterly CFI is now -1557.42% below its all-time high of $480.30 thousand, reached on 30 April 2007.PMCB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$12.00 M
-$7.00 M-140.00%
31 July 2024
Summary:
PharmaCyte Biotech TTM cash flow from investing activities is currently -$12.00 million, with the most recent change of -$7.00 million (-140.00%) on 31 July 2024. Over the past year, it has dropped by -$12.00 million (-100.00%). PMCB TTM CFI is now -2441.01% below its all-time high of $512.60 thousand, reached on 31 October 2005.PMCB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | -100.0% |
| 3 y3 years | -100.0% | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% | -100.0% |
PMCB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at low | at low | at low | |||
| 5 y | 5 years | at low | at low | at low | |||
| alltime | all time | -3268.6% | at low | -1557.4% | at low | -2441.0% | at low |
PharmaCyte Biotech Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | -$7.00 M(<-9900.0%) | -$12.00 M(+140.0%) |
| Apr 2024 | -$5.00 M(<-9900.0%) | $0.00(-100.0%) | -$5.00 M(0.0%) |
| Jan 2024 | - | -$5.00 M(<-9900.0%) | -$5.00 M(<-9900.0%) |
| Oct 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2023 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2022 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2021 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2020 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2019 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2018 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2017 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| July 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2016 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2015 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Oct 2014 | - | $0.00(0.0%) | -$1.01 M(-49.4%) |
| July 2014 | - | $0.00(-100.0%) | -$1.99 M(-44.1%) |
| Apr 2014 | -$3.56 M(+450.3%) | -$1.01 M(<-9900.0%) | -$3.56 M(+31.0%) |
| Jan 2014 | - | $0.00(-100.0%) | -$2.72 M(-5.6%) |
| Oct 2013 | - | -$982.40 K(-37.4%) | -$2.88 M(+42.4%) |
| July 2013 | - | -$1.57 M(+850.8%) | -$2.02 M(+212.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2013 | -$646.80 K(-25.8%) | -$165.00 K(+3.1%) | -$646.80 K(-4.0%) |
| Jan 2013 | - | -$160.00 K(+27.0%) | -$673.50 K(+6.3%) |
| Oct 2012 | - | -$126.00 K(-35.6%) | -$633.50 K(-15.3%) |
| July 2012 | - | -$195.80 K(+2.1%) | -$747.50 K(-14.2%) |
| Apr 2012 | -$871.70 K(<-9900.0%) | -$191.70 K(+59.8%) | -$871.70 K(+28.2%) |
| Jan 2012 | - | -$120.00 K(-50.0%) | -$680.00 K(+21.4%) |
| Oct 2011 | - | -$240.00 K(-25.0%) | -$560.00 K(+75.0%) |
| July 2011 | - | -$320.00 K(<-9900.0%) | -$320.00 K(<-9900.0%) |
| Apr 2011 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Jan 2011 | - | $0.00(0.0%) | $46.30 K(0.0%) |
| Oct 2010 | - | $0.00(0.0%) | $46.30 K(0.0%) |
| July 2010 | - | $0.00(-100.0%) | $46.30 K(-38.3%) |
| Apr 2010 | $75.00 K(-647.4%) | $46.30 K(>+9900.0%) | $75.00 K(+151.7%) |
| Jan 2010 | - | $0.00(0.0%) | $29.80 K(+88.6%) |
| Oct 2009 | - | $0.00(-100.0%) | $15.80 K(+1.3%) |
| July 2009 | - | $28.70 K(+2509.1%) | $15.60 K(-214.7%) |
| Apr 2009 | -$13.70 K(+42.7%) | $1100.00(-107.9%) | -$13.60 K(-162.4%) |
| Jan 2009 | - | -$14.00 K(+6900.0%) | $21.80 K(-80.7%) |
| Oct 2008 | - | -$200.00(-60.0%) | $112.80 K(-2150.9%) |
| July 2008 | - | -$500.00(-101.4%) | -$5500.00(-42.1%) |
| Apr 2008 | -$9600.00(-98.6%) | $36.50 K(-52.6%) | -$9500.00(-102.2%) |
| Jan 2008 | - | $77.00 K(-165.0%) | $434.30 K(-153.2%) |
| Oct 2007 | - | -$118.50 K(+2533.3%) | -$817.00 K(+17.0%) |
| July 2007 | - | -$4500.00(-100.9%) | -$698.50 K(+0.6%) |
| Apr 2007 | -$694.00 K(-539.8%) | $480.30 K(-140.9%) | -$694.00 K(-41.1%) |
| Jan 2007 | - | -$1.17 M(<-9900.0%) | -$1.18 M(>+9900.0%) |
| Oct 2006 | - | $0.00(0.0%) | -$4100.00(-40.6%) |
| July 2006 | - | $0.00(-100.0%) | -$6900.00(-104.4%) |
| Apr 2006 | $157.80 K(-168.4%) | -$4100.00(<-9900.0%) | $157.80 K(-50.7%) |
| Jan 2006 | - | $0.00(-100.0%) | $320.10 K(-37.6%) |
| Oct 2005 | - | -$2800.00(-101.7%) | $512.60 K(+12.2%) |
| July 2005 | - | $164.70 K(+4.1%) | $457.00 K(-298.2%) |
| Apr 2005 | -$230.60 K(+412.4%) | $158.20 K(-17.8%) | -$230.60 K(-46.8%) |
| Jan 2005 | - | $192.50 K(-429.6%) | -$433.80 K(-30.7%) |
| Oct 2004 | - | -$58.40 K(-88.8%) | -$626.30 K(+10.3%) |
| July 2004 | - | -$522.90 K(+1062.0%) | -$567.90 K(+1162.0%) |
| Apr 2004 | -$45.00 K(<-9900.0%) | -$45.00 K(<-9900.0%) | -$45.00 K(<-9900.0%) |
| Jan 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2003 | - | $0.00 | $0.00 |
| Apr 2003 | $0.00(0.0%) | - | - |
| Apr 2002 | $0.00 | - | - |
FAQ
- What is PharmaCyte Biotech annual cash flow from investing activities?
- What is the all time high annual CFI for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual CFI year-on-year change?
- What is PharmaCyte Biotech quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly CFI year-on-year change?
- What is PharmaCyte Biotech TTM cash flow from investing activities?
- What is the all time high TTM CFI for PharmaCyte Biotech?
- What is PharmaCyte Biotech TTM CFI year-on-year change?
What is PharmaCyte Biotech annual cash flow from investing activities?
The current annual CFI of PMCB is -$5.00 M
What is the all time high annual CFI for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual cash flow from investing activities is $157.80 K
What is PharmaCyte Biotech annual CFI year-on-year change?
Over the past year, PMCB annual cash flow from investing activities has changed by -$5.00 M (-100.00%)
What is PharmaCyte Biotech quarterly cash flow from investing activities?
The current quarterly CFI of PMCB is -$7.00 M
What is the all time high quarterly CFI for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly cash flow from investing activities is $480.30 K
What is PharmaCyte Biotech quarterly CFI year-on-year change?
Over the past year, PMCB quarterly cash flow from investing activities has changed by -$7.00 M (-100.00%)
What is PharmaCyte Biotech TTM cash flow from investing activities?
The current TTM CFI of PMCB is -$12.00 M
What is the all time high TTM CFI for PharmaCyte Biotech?
PharmaCyte Biotech all-time high TTM cash flow from investing activities is $512.60 K
What is PharmaCyte Biotech TTM CFI year-on-year change?
Over the past year, PMCB TTM cash flow from investing activities has changed by -$12.00 M (-100.00%)